Related Experiment Video
Updated: Aug 23, 2026

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus
Yulia Alejandra Flores-Martínez1, Vu Thuy Khanh Le-Trilling1, Mirko Trilling1
1Institute for Virology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Abstract:
Human cytomegalovirus causes diseases in individuals with insufficient immunity. Cytomegaloviruses exploit the ubiquitin proteasome pathway to manipulate the proteome of infected cells. The proteasome degrades ubiquitinated proteins. The family of cullin RING ubiquitin ligases (CRL) regulates the stability of numerous important proteins. If the cullin within the CRL is modified with Nedd8 ("neddylated"), the CRL is enzymatically active, while CRLs lacking Nedd8 modifications are inactive. The Nedd8-activating enzyme (NAE) is indispensable for neddylation. By binding to NAE and inhibiting neddylation, the drug MLN4924 (pevonedistat) causes CRL inactivation and stabilization of CRL target proteins. We showed that MLN4924 elicits potent antiviral activity against cytomegaloviruses, suggesting that NAE might be a druggable host dependency factor (HDF). However, MLN4924 is a nucleoside analog related to AMP, and the antiviral activity of MLN4924 may have been influenced by off-target effects in addition to NAE inhibition. To test if NAE is indeed an HDF, we assessed the novel NAE inhibitor TAS4464 and observed potent antiviral activity against mouse and human cytomegalovirus. Additionally, we raised an MLN4924-resistant cell clone and showed that MLN4924 as well as TAS4464 lose their antiviral activity in these cells. Our results indicate that NAE, the neddylation process, and CRLs are druggable HDFs of cytomegaloviruses.
Insights
The Nedd8-activating enzyme (NAE) and its neddylation process are crucial for cytomegalovirus replication. Inhibiting NAE with drugs like MLN4924 and TAS4464 shows potent antiviral activity, identifying NAE as a druggable host dependency factor.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Human cytomegalovirus (CMV) infections pose significant risks to immunocompromised individuals.
- CMV manipulates host cell proteasome pathways, including cullin RING ligases (CRLs), for replication.
- CRL activity is regulated by Nedd8 modification, a process dependent on the Nedd8-activating enzyme (NAE).
Purpose of the Study:
- To investigate the Nedd8-activating enzyme (NAE) as a potential druggable host dependency factor (HDF) for cytomegaloviruses.
- To validate the antiviral efficacy of NAE inhibitors against both human and mouse CMV.
- To confirm the specificity of NAE inhibition in conferring antiviral activity.
Main Methods:
- Utilized the NAE inhibitor MLN4924 (pevonedistat) and a novel NAE inhibitor, TAS4464.
- Assessed antiviral activity against human and mouse cytomegalovirus strains.
- Generated and utilized a cell clone resistant to MLN4924 to evaluate drug specificity.
Main Results:
- Both MLN4924 and TAS4464 demonstrated potent antiviral activity against cytomegaloviruses.
- Antiviral activity of both NAE inhibitors was significantly reduced or abolished in the MLN4924-resistant cells.
- These findings strongly suggest NAE is essential for CMV replication.
Conclusions:
- The Nedd8-activating enzyme (NAE), the neddylation process, and CRLs represent viable and druggable host dependency factors for cytomegaloviruses.
- Targeting NAE offers a promising therapeutic strategy for managing CMV infections, particularly in vulnerable populations.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Cytomegalovirus Disease
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors

